Patti Elaine Gravitt - Professor in Department of Pathology

Welcome to the University of New Mexico Department of Pathology. This is an energizing time for the eventual fate of pathology here in New Mexico and across the nation. New advances in the sub-atomic portrayal of ailment and sub-atomic diagnostics guarantee to enhance sickness avoidance and treatment. Pathologists are in a perfect world arranged to decipher fundamental science research revelations to enhance patient care and turn into the guards for customized solution.

Patti E.gravitt is professor in Department of Pathology University of New Mexico Health Sciences Center MSC08 4640 1 University of New Mexico. Patti done BS and MS from University of North Carolina at Charlotte, Charlotte NC and PhD from Johns Hopkins University, Bloomberg School of Public Health, and Baltimore, MD. Patti E. gravitt having lot of professional experienced Assistance Professor at Department of Molecular Microbiology and Immunology and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (2008-2013). Currently professor at Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM

PUBLICATIONS

Journal Articles

1. Gravitt P, Hakenewerth A, Stoerker J. A direct comparison of methods porposed for use in widespread screening of human papillomavirus infections. Mol Cell Probes. 1991;5:64-72.

2. Ibrahim GK, Gravitt PE, Dittrich KL, Ibrahim SN, Melhus O, Anderson SM, Robertson CN. Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol. 1992;148:1822-6. 

3. Kemp EA, Hakenewerth AM, Laurent SL, Gravitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol. 1992;79:649-56.

4. Kuypers JM, Critchlow CW, Gravitt PE, Vernon DA, Sayer JB, Manos MM, Kiviat NB. Comparison of detection of dot filter hybridization, Southern transfer hybridization, and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection. J Clin Micro. 1993;31:1003-6.

5. Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, Tchabo JG, Brinton LA, Copeland C, Epp J, Manos MM. Determinants of genital human papillomavirus infection in low-income women in Washinton, D.C. Sex Transm Dis 1993;20:279-85. (Time cited: 123)

6. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manos MM. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994;169:235-40. (Times cited: 472)

7. Stewart A-C, Gravitt PE, Cheng S, and Wheeler CM. Generation of entire human papillomavirus genomes by long PCR: frequency of errors produced during amplification. Genome Res. 1995;5:79-88.

8. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998;36:3020-7. (Times cited: 337)

9. Coutlee F, Gravitt P, Richardson H, Hankins C, Franco E, Lapointe N, Voyer H, The Canadian Women’s HIV Study Group. Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. J Clin Microbiol. 1999;37:1852-7.

10. Lacey JV Jr, Brinton LA, Abbas FM, Barnes WM, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel L, Schwartz PE, Silverberg SG, Hildesheim A. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev. 1999;8:1079-85.